Antibacterial Therapy in Adults with COVID-19

Since the emergence of the Coronavirus-19 infectious disease (COVID-19) pandemic, a rising number of reports have underlined the risk of increasing antimicrobial resistance due to antibiotic overuse in COVID-19 patients. In addition, many physicians and pharmacists involved in antimicrobial stewards...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Weitere Verfasser:	Allard, Sabine Danielle (Herausgegeben von), Van Laethem, Johan (Herausgegeben von)
Format:	Elektronisch Buchkapitel
Sprache:	Englisch
Veröffentlicht:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Schlagworte:	Medicine Clinical & internal medicine COVID-19 antimicrobial use multicentre point-prevalence study Influenza co-infection secondary infections aspergillosis ivermectin randomized-controlled trial prevention treatment SARS-CoV-2 antiviral antibiotic azithromycin remdesivir macrolides virus coronavirus immunolides antivirus pandemics procalcitonin SARS virus community-acquired infections emergency service hospital pneumonia viral community-acquired pneumonia Mid-regional Pro-adrenomedullin ARDS biomarker prognosis superinfection bacterial co-infection bacterial superinfection antibiotic stewardship AMR antibiotics cephalosporin secondary infection variant of concern interleukin-6 receptor antagonist early administration mortality rates
Online-Zugang:	DOAB: download the publication DOAB: description of the publication
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Antibacterial Therapy in Adults with COVID-19

Veröffentlicht 2023

DOAB: download the publication
DOAB: description of the publication

Elektronisch Buchkapitel

Antibacterial Therapy in Adults with COVID-19

Antibacterial Therapy in Adults with COVID-19

Ähnliche Einträge